Silver Spring, MD, United States of America

Marina Nikolaevna Protopopova

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Sequella, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services, Other. Active years: 2002-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marina Nikolaevna Protopopova. Retrieved from https://idiyas.com/inventor/marina-nikolaevna-protopopova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 62.5



Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Chicago, IL (US) (2002)
  • Silver Springs, MD (US) (2008 - 2010)
  • Silver Spring, MD (US) (2005 - 2012)

Company Filing History:


Years Active: 2002-2012

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Marina Nikolaevna Protopopova: Innovator in Infectious Disease Treatment

Introduction

Marina Nikolaevna Protopopova is a distinguished inventor based in Silver Spring, MD, known for her significant contributions to the field of infectious diseases. With a total of eight patents to her name, she has focused her research on developing innovative methods and compositions for treating diseases caused by infectious agents, particularly tuberculosis.

Latest Patents

Among her latest patents, Protopopova has developed compositions and methods for the treatment of infectious diseases. These include methods and compositions that utilize substituted ethylene diamines specifically for treating mycobacterial infections, including tuberculosis. Another notable patent involves methods of use and compositions for the diagnosis and treatment of infectious diseases, again focusing on tuberculosis and utilizing substituted diamines.

Career Highlights

Throughout her career, Protopopova has worked with reputable organizations such as Sequella, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. Her work in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Protopopova has collaborated with esteemed colleagues, including Elena Bogatcheva and Richard Edward Lee, enhancing her research through shared expertise and innovative ideas.

Conclusion

Marina Nikolaevna Protopopova's work in the treatment of infectious diseases, particularly tuberculosis, showcases her dedication to advancing medical science. Her numerous patents reflect her innovative spirit and commitment to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…